TRAX

MKT CAP:$631M

First Tracks Biotherapeutics

Market Cap

$631M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$16.60+$3.93 (+31.02%)

Jun 5, 2026

52W High $25.4052W Low $11.61

Company Details

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 ant...

CEO

—

IPO Date

Apr 20, 2026

Website

www.firsttracksbio.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$50M

EPS (Diluted)

Free Cash Flow

-$33M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

Mar 31, 2026

FY 2025

Dec 31, 2025

Q1 2025

Mar 31, 2025

FY 2024

Dec 31, 2024

FY 2023

Dec 31, 2023

Revenue & Profitability

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee